Deerfield Special Situations Fund, L.P.
Insider CIK 1354395 · STRM 10% owner · AVDL · ATRS 10% owner · CBIO 10% owner · XNPT 10% owner · TLON.OB 10% owner · ALIM 10% owner · EHTH 10% owner · AERI 10% owner · LIFE 10% owner · XERS 10% owner · VNDA 10% owner · PRTO 10% owner · ZFGN 10% owner · IVTY 10% owner · DRNA 10% owner · TRIV 10% owner · CNST 10% owner · ASPX 10% owner · NEOS 10% owner · NVTA 10% owner · AAVL 10% owner · CTMX 10% owner · SYRS 10% owner · ACRS · LOXO 10% owner · REPH 10% owner · STDY 10% owner · NVLS 10% owner · BOLD 10% owner · SWAV 10% owner · RYTM 10% owner · AVXS 10% owner · ARVN 10% owner · FREQ 10% owner · KNSA 10% owner · CABA 10% owner · MIRM 10% owner · CASM 10% owner · AXGN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-09 | 2021-07-13 | 99,325 | $15.81 | $1.57M | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-07 | 2021-07-07 | 6,837 | $15.87 | $108.5K | 99,325 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-06 | 2021-07-07 | 49,239 | $16.20 | $797.7K | 106,162 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-07-02 | 2021-07-07 | 10,599 | $17.01 | $180.3K | 155,401 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 696,379 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 696,379 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2019-10-29 | 2019-10-30 | 700,000 | $11.00 | $7.70M | 700,000 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 464,253 | — | $0 | 464,253 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 464,253 | — | $0 | 464,253 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-07 | 3,184,948 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion deriv | 2019-10-07 | 2019-10-07 | 3,184,948 | — | $0 | 0 | SEC↗ |
| FREQ Frequency Therapeutics, In | P Buy | 2019-10-07 | 2019-10-07 | 285,714 | $14.00 | $4.00M | 285,714 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion | 2019-10-07 | 2019-10-07 | 472,860 | — | $0 | 472,860 | SEC↗ |
| FREQ Frequency Therapeutics, In | C Conversion | 2019-10-07 | 2019-10-07 | 472,860 | — | $0 | 472,860 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 12,467,650 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 12,467,650 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 1,558,456 | — | $0 | 1,558,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 1,558,456 | — | $0 | 1,558,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 166,000 | $15.00 | $2.49M | 1,724,456 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 166,000 | $15.00 | $2.49M | 166,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-27 | 2019-07-01 | 108,674 | $2.69 | $292.3K | 964,101 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-27 | 2019-07-01 | 590,801 | $2.69 | $1.59M | 3,159,165 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-26 | 2019-06-26 | 352 | $4.50 | $1.6K | 1,072,775 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-26 | 2019-06-26 | 1,352 | $4.50 | $6.1K | 3,749,966 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-25 | 2019-06-25 | 10,634 | $4.51 | $48.0K | 1,073,127 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-25 | 2019-06-25 | 40,850 | $4.51 | $184.2K | 3,751,318 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-24 | 2019-06-25 | 13,063 | $4.52 | $59.0K | 1,083,761 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-24 | 2019-06-25 | 50,177 | $4.52 | $226.8K | 3,792,168 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-21 | 2019-06-25 | 70,135 | $4.62 | $324.0K | 1,096,824 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-06-21 | 2019-06-25 | 269,402 | $4.62 | $1.24M | 3,842,345 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-10 | 2019-05-13 | 108,696 | $6.05 | $657.6K | 4,111,747 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-10 | 2019-05-13 | 71,869 | $6.05 | $434.8K | 1,166,959 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-09 | 2019-05-13 | 172,800 | $6.16 | $1.06M | 1,238,828 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2019-05-09 | 2019-05-13 | 261,345 | $6.16 | $1.61M | 4,220,443 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 1,619,433 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 284,659 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 1,619,433 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion deriv | 2019-03-11 | 2019-03-11 | 284,659 | — | $0 | 0 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 23,333 | — | $0 | 156,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 166,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 166,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | P Buy | 2019-03-11 | 2019-03-11 | 10,000 | $17.00 | $170.0K | 10,000 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 132,740 | — | $0 | 132,740 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 23,333 | — | $0 | 156,073 | SEC↗ |
| SWAV ShockWave Medical, Inc. | C Conversion | 2019-03-11 | 2019-03-11 | 132,740 | — | $0 | 132,740 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-12 | 1,351 | $15.00 | $20.3K | 856,470 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-08 | 2019-02-12 | 5,890 | $15.11 | $89.0K | 857,821 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-07 | 2019-02-07 | 9,409 | $15.00 | $141.1K | 863,711 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-06 | 2019-02-07 | 400 | $15.00 | $6.0K | 873,120 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-02-05 | 2019-02-07 | 4,998 | $15.07 | $75.3K | 873,520 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-29 | 2019-01-30 | 6,210 | $15.14 | $94.0K | 878,518 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-28 | 2019-01-30 | 828 | $15.00 | $12.4K | 884,728 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-25 | 2019-01-25 | 76,820 | $15.08 | $1.16M | 885,556 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-24 | 2019-01-25 | 5,425 | $15.03 | $81.5K | 962,376 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-23 | 2019-01-25 | 32,199 | $16.35 | $526.5K | 967,801 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-15 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-14 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2019-01-11 | 2019-01-18 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-28 | 2019-01-02 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-27 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-26 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-24 | 2018-12-27 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-21 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-20 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other deriv | 2018-12-19 | 2018-12-21 | 1 | — | $0 | 1 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion deriv | 2018-10-01 | 2018-10-01 | 998,004 | — | $0 | 0 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,167 | $16.00 | $1.67M | 411,245 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,167 | $16.00 | $1.67M | 411,245 | SEC↗ |
| ARVN ARVINAS INC. | P Buy | 2018-10-01 | 2018-10-01 | 104,166 | $16.00 | $1.67M | 411,244 | SEC↗ |
| ARVN ARVINAS INC. | C Conversion | 2018-10-01 | 2018-10-01 | 307,078 | — | $0 | 307,078 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion deriv | 2018-07-23 | 2018-07-23 | 7,000,000 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | C Conversion | 2018-07-23 | 2018-07-23 | 635,843 | — | $0 | 635,843 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | P Buy | 2018-07-23 | 2018-07-23 | 200,000 | $15.00 | $3.00M | 835,843 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,557,292 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 1,557,292 | — | $0 | 0 | SEC↗ |
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2018-06-25 | 2018-06-25 | 114,034 | $5.99 | $683.1K | 952,265 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2018-06-25 | 2018-06-27 | 624,333 | $15.00 | $9.36M | 1,498,666 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 874,333 | — | $0 | 874,333 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 874,333 | — | $0 | 874,333 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | P Buy | 2018-06-25 | 2018-06-27 | 125,667 | $15.00 | $1.89M | 1,000,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-31 | 383,538 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 25,000 | $20.91 | $522.8K | 608,333 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 250,000 | $19.81 | $4.95M | 583,333 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 235,019 | $19.24 | $4.52M | 843,352 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-31 | 383,538 | — | $0 | 383,538 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | P Buy | 2018-05-29 | 2018-05-31 | 333,333 | $18.00 | $6.00M | 333,333 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-08 | 8,123 | $29.03 | $235.8K | 1,113,222 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-08 | 1,194 | $30.00 | $35.8K | 1,121,345 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 5,890 | $29.03 | $171.0K | 807,257 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 866 | $30.00 | $26.0K | 813,147 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 2,233 | $29.03 | $64.8K | 305,965 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-08 | 2018-03-21 | 328 | $30.00 | $9.8K | 308,198 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-07 | 2018-03-08 | 10,000 | $30.00 | $300.0K | 1,122,539 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-07 | 2018-03-21 | 2,748 | $30.00 | $82.4K | 308,526 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-07 | 2018-03-21 | 7,252 | $30.00 | $217.6K | 814,013 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-08 | 39,300 | $31.18 | $1.23M | 1,132,539 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-08 | 13,161 | $29.94 | $394.0K | 1,171,839 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 10,802 | $31.18 | $336.8K | 311,274 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 28,498 | $31.18 | $888.6K | 821,265 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 3,617 | $29.94 | $108.3K | 322,076 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | S Sale | 2018-03-06 | 2018-03-21 | 9,544 | $29.94 | $285.7K | 849,763 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,668,518 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,668,518 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 177,500 | $17.00 | $3.02M | 468,505 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 291,005 | — | $0 | 291,005 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 291,005 | — | $0 | 291,005 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 177,500 | $17.00 | $3.02M | 468,505 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-14 | 2017-06-14 | 68,000 | $6.25 | $425.0K | 1,176,685 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-13 | 2017-06-14 | 32,447 | $6.59 | $213.8K | 1,244,685 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-12 | 2017-06-14 | 10,000 | $6.74 | $67.4K | 1,277,132 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-08 | 2017-06-09 | 17,245 | $6.99 | $120.5K | 1,287,132 | SEC↗ |
| REPH Recro Pharma, Inc. | S Sale | 2017-06-07 | 2017-06-09 | 45,623 | $7.09 | $323.5K | 1,304,377 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 183,805 | $11.71 | $2.15M | 244,562 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 71,837 | $11.71 | $841.2K | 877,606 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-27 | 2017-04-27 | 58,067 | $11.71 | $680.0K | 709,386 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 66,351 | $11.52 | $764.4K | 428,367 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 20,962 | $11.52 | $241.5K | 767,453 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-26 | 2017-04-27 | 25,932 | $11.52 | $298.7K | 949,443 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 34,349 | $11.00 | $377.8K | 975,375 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 87,886 | $11.00 | $966.7K | 494,718 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-13 | 2017-04-17 | 27,765 | $11.00 | $305.4K | 788,415 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 6,189 | $11.01 | $68.1K | 816,180 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 19,593 | $11.01 | $215.7K | 582,604 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-11 | 2017-04-11 | 7,658 | $11.01 | $84.3K | 1,009,724 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 18,264 | $11.04 | $201.6K | 1,017,382 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 14,763 | $11.04 | $163.0K | 822,369 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-10 | 2017-04-11 | 46,730 | $11.04 | $515.9K | 602,197 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-07 | 2017-04-11 | 27,228 | $11.72 | $319.1K | 1,035,646 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-07 | 2017-04-11 | 22,009 | $11.72 | $257.9K | 837,132 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2017-04-07 | 2017-04-11 | 69,667 | $11.72 | $816.5K | 648,927 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-26 | 2017-01-26 | 517,450 | $1.46 | $755.5K | 2,358,636 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-25 | 2017-01-26 | 71,468 | $1.50 | $107.2K | 2,876,086 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-24 | 2017-01-26 | 47,320 | $1.50 | $71.0K | 2,947,554 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-23 | 2017-01-23 | 86,691 | $1.47 | $127.4K | 2,994,874 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-20 | 2017-01-23 | 46,522 | $1.53 | $71.2K | 3,081,565 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | S Sale | 2017-01-19 | 2017-01-23 | 71,913 | $1.60 | $115.1K | 3,128,087 | SEC↗ |
| IVTY Invuity, Inc. | S Sale | 2016-12-14 | 2016-12-14 | 45,568 | $6.01 | $273.9K | 1,690,498 | SEC↗ |
| IVTY Invuity, Inc. | S Sale | 2016-12-13 | 2016-12-14 | 71,173 | $6.13 | $436.3K | 1,736,066 | SEC↗ |
| IVTY Invuity, Inc. | S Sale | 2016-12-12 | 2016-12-14 | 68,055 | $6.45 | $439.0K | 1,807,239 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-23 | 2016-09-26 | 157,607 | $16.71 | $2.63M | 693,171 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-23 | 2016-09-26 | 348,258 | $16.71 | $5.82M | 2,035,697 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-23 | 2016-09-26 | 273,632 | $16.71 | $4.57M | 1,599,476 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-22 | 2016-09-26 | 68,940 | $16.24 | $1.12M | 850,778 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-22 | 2016-09-26 | 152,334 | $16.24 | $2.47M | 2,383,955 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-22 | 2016-09-26 | 119,690 | $16.24 | $1.94M | 1,873,108 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-19 | 2016-09-19 | 4,910 | $15.53 | $76.3K | 2,536,289 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-19 | 2016-09-19 | 3,857 | $15.53 | $59.9K | 1,992,798 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-19 | 2016-09-19 | 37,044 | $15.58 | $577.1K | 919,718 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-16 | 2016-09-19 | 119,008 | $15.62 | $1.86M | 2,541,199 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-16 | 2016-09-19 | 87,858 | $15.62 | $1.37M | 956,762 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-16 | 2016-09-19 | 93,506 | $15.62 | $1.46M | 1,996,655 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-15 | 2016-09-19 | 58,997 | $15.76 | $929.8K | 1,044,620 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-15 | 2016-09-19 | 79,915 | $15.76 | $1.26M | 2,660,207 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2016-09-15 | 2016-09-19 | 62,791 | $15.76 | $989.6K | 2,090,161 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 267,998 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 535,996 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 267,998 | — | $0 | 267,998 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 535,996 | — | $0 | 535,996 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 635,826 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 253,404 | $15.00 | $3.80M | 889,230 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 146,596 | $15.00 | $2.20M | 514,424 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 99,830 | — | $0 | 367,828 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2016-07-21 | 2016-07-21 | 102,136 | $6.70 | $684.3K | 3,000,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | S Sale | 2016-07-20 | 2016-08-01 | 246,439 | $3.31 | $815.7K | 314,889 | SEC↗ |
| ZFGN ZAFGEN, INC. | S Sale | 2016-07-20 | 2016-08-01 | 901,430 | $3.31 | $2.98M | 1,151,802 | SEC↗ |
| ZFGN ZAFGEN, INC. | S Sale | 2016-07-20 | 2016-08-01 | 193,630 | $3.31 | $640.9K | 247,413 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2016-07-18 | 2016-07-18 | 41,425 | $6.87 | $284.6K | 3,102,136 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2016-07-15 | 2016-07-18 | 31,788 | $7.32 | $232.7K | 3,143,561 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2016-07-14 | 2016-07-18 | 206,090 | $7.70 | $1.59M | 3,175,349 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 508,566 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-06 | 1,186,654 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-06 | 120,000 | $12.50 | $1.50M | 628,566 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-06 | 280,000 | $12.50 | $3.50M | 1,466,654 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 508,566 | — | $0 | 508,566 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-06 | 1,186,654 | — | $0 | 1,186,654 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-21 | 2016-06-22 | 26,400 | $14.30 | $377.5K | 718,594 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-20 | 2016-06-22 | 178,454 | $14.20 | $2.53M | 744,994 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-14 | 2016-06-16 | 43,300 | $13.88 | $601.0K | 923,448 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-08 | 2016-06-08 | 28,080 | $13.84 | $388.6K | 966,748 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-07 | 2016-06-08 | 7,154 | $13.89 | $99.4K | 994,828 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-06 | 2016-06-08 | 28,502 | $14.00 | $399.0K | 1,001,982 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-02 | 2016-06-02 | 42,668 | $13.87 | $591.8K | 1,030,484 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-06-01 | 2016-06-02 | 5 | $13.80 | $69 | 1,073,152 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-05-31 | 2016-06-02 | 56,835 | $13.84 | $786.6K | 1,073,157 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-05-27 | 2016-05-27 | 72,649 | $14.00 | $1.02M | 1,129,992 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-05-26 | 2016-05-27 | 93,965 | $14.16 | $1.33M | 1,202,641 | SEC↗ |
| EHTH eHealth, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 45,967 | $14.25 | $655.0K | 1,296,606 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 1,182,941 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 117,998 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 117,996 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion deriv | 2016-02-17 | 2016-02-19 | 67,448 | — | $0 | 0 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 122,793 | $20.00 | $2.46M | 1,623,089 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 117,998 | — | $0 | 249,909 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 117,996 | — | $0 | 1,500,296 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 1,182,941 | — | $0 | 1,382,300 | SEC↗ |
| AVXS AveXis, Inc. | C Conversion | 2016-02-17 | 2016-02-19 | 67,448 | — | $0 | 199,359 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 112,000 | $20.00 | $2.24M | 112,000 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 88,000 | $20.00 | $1.76M | 88,000 | SEC↗ |
| AVXS AveXis, Inc. | P Buy | 2016-02-17 | 2016-02-19 | 163,702 | $20.00 | $3.27M | 413,611 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-12 | 2016-02-17 | 13,872 | $6.25 | $86.7K | 2,053,232 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-12 | 2016-02-17 | 22,296 | $6.25 | $139.3K | 441,043 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-12 | 2016-02-17 | 28,377 | $6.25 | $177.4K | 561,328 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-11 | 2016-02-11 | 810 | $6.19 | $5.0K | 418,747 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-11 | 2016-02-11 | 1,030 | $6.19 | $6.4K | 532,951 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-11 | 2016-02-11 | 504 | $6.19 | $3.1K | 2,039,360 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-10 | 2016-02-11 | 52,239 | $6.23 | $325.4K | 417,937 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-10 | 2016-02-11 | 66,486 | $6.23 | $414.2K | 531,921 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-10 | 2016-02-11 | 32,501 | $6.23 | $202.5K | 2,038,856 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-09 | 2016-02-11 | 39,353 | $5.73 | $225.5K | 365,698 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-09 | 2016-02-11 | 50,086 | $5.73 | $287.0K | 465,435 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2016-02-09 | 2016-02-11 | 24,484 | $5.73 | $140.3K | 2,006,355 | SEC↗ |
| XNPT XENOPORT INC | P Buy | 2016-01-20 | 2016-01-22 | 346,417 | $4.09 | $1.42M | 6,667,391 | SEC↗ |
| STRM STREAMLINE HEALTH SOLUTION | S Sale | 2015-12-17 | 2015-12-17 | 226,000 | $1.20 | $271.2K | 1,875,500 | SEC↗ |
| STRM STREAMLINE HEALTH SOLUTION | S Sale | 2015-12-16 | 2015-12-17 | 116,464 | $1.23 | $143.3K | 2,101,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-16 | 2015-12-18 | 4,441 | $8.97 | $39.8K | 2,740,122 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-16 | 2015-12-18 | 3,239 | $8.97 | $29.1K | 1,103,617 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-16 | 2015-12-18 | 3,490 | $8.97 | $31.3K | 2,152,952 | SEC↗ |
| STRM STREAMLINE HEALTH SOLUTION | S Sale | 2015-12-15 | 2015-12-17 | 54,795 | $1.34 | $73.4K | 2,217,964 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-11 | 100,864 | $8.61 | $868.4K | 2,158,248 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-11 | 93,634 | $8.61 | $806.2K | 1,100,378 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-11 | 128,374 | $8.61 | $1.11M | 2,726,895 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-18 | 100,864 | $8.61 | $868.4K | 2,149,462 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-18 | 128,374 | $8.61 | $1.11M | 2,735,681 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-11 | 2015-12-18 | 93,634 | $8.61 | $806.2K | 1,100,378 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-11 | 29,902 | $8.59 | $256.9K | 1,006,744 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-11 | 32,211 | $8.59 | $276.7K | 2,598,521 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-11 | 40,997 | $8.59 | $352.2K | 2,057,384 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-18 | 40,997 | $8.59 | $352.2K | 2,607,307 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-18 | 32,211 | $8.59 | $276.7K | 2,048,598 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-10 | 2015-12-18 | 29,902 | $8.59 | $256.9K | 1,006,744 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 12,395 | $9.00 | $111.6K | 2,016,387 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 11,506 | $9.00 | $103.6K | 976,842 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 15,775 | $9.00 | $142.0K | 2,566,310 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 213,358 | $8.21 | $1.75M | 965,336 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 292,515 | $8.21 | $2.40M | 2,550,535 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | P Buy | 2015-12-09 | 2015-12-11 | 229,833 | $8.21 | $1.89M | 2,003,992 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,530 | $3.04 | $83.7K | 728,718 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,529 | $3.04 | $83.7K | 4,760,408 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 4,732,879 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 701,188 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 632,894 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 4,664,585 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,486 | $3.00 | $160.5K | 4,624,284 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,487 | $3.00 | $160.5K | 592,593 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 539,106 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 4,570,798 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,882 | $3.05 | $39.3K | 483,849 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,883 | $3.05 | $39.3K | 4,515,541 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 470,967 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 4,502,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 4,466,033 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 434,342 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 426,071 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 4,457,762 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 412,906 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 4,444,597 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,117 | $3.00 | $51.4K | 396,400 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,116 | $3.00 | $51.3K | 4,428,091 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,091 | $3.00 | $36.3K | 4,410,975 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,090 | $3.00 | $36.3K | 379,283 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 4,398,884 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 367,193 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 366,218 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 4,397,909 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 4,317,567 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 285,876 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 4,267,502 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 235,811 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion deriv | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 160,512 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | P Buy | 2015-10-14 | 2015-10-14 | 114,488 | $12.00 | $1.37M | 275,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | C Conversion | 2015-10-14 | 2015-10-14 | 160,512 | — | $0 | 160,512 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | P Buy | 2015-10-14 | 2015-10-14 | 510,512 | $12.00 | $6.13M | 671,024 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 171,198 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 4,202,889 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,817 | $2.50 | $49.5K | 99,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,816 | $2.50 | $49.5K | 4,131,349 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 79,841 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 4,111,533 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-30 | 2015-09-30 | 106,820 | $1.69 | $180.5K | 6,807,533 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-30 | 2015-09-30 | 59,248 | $1.69 | $100.1K | 3,294,817 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-30 | 2015-09-30 | 83,930 | $1.69 | $141.8K | 5,348,776 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 34,450 | $1.83 | $63.0K | 5,432,706 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 43,845 | $1.83 | $80.2K | 6,914,353 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 11,081 | $1.82 | $20.2K | 3,354,065 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 15,696 | $1.82 | $28.6K | 5,467,156 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 19,976 | $1.82 | $36.4K | 6,958,198 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 23,700 | $1.81 | $42.9K | 3,365,146 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 33,572 | $1.81 | $60.8K | 5,482,852 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-29 | 2015-09-30 | 42,728 | $1.81 | $77.3K | 6,978,174 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-28 | 2015-09-30 | 226,857 | $1.80 | $408.3K | 5,885,100 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-28 | 2015-09-30 | 368,676 | $1.81 | $667.3K | 5,516,424 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-09-28 | 2015-09-30 | 469,224 | $1.81 | $849.3K | 7,020,902 | SEC↗ |